CN116042502A - Genetically engineered bacterium capable of secreting mussel protein extracellularly, construction method and application thereof - Google Patents
Genetically engineered bacterium capable of secreting mussel protein extracellularly, construction method and application thereof Download PDFInfo
- Publication number
- CN116042502A CN116042502A CN202310168298.6A CN202310168298A CN116042502A CN 116042502 A CN116042502 A CN 116042502A CN 202310168298 A CN202310168298 A CN 202310168298A CN 116042502 A CN116042502 A CN 116042502A
- Authority
- CN
- China
- Prior art keywords
- mussel
- genetically engineered
- signal peptide
- mussel protein
- engineered bacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 94
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 74
- 241000237536 Mytilus edulis Species 0.000 title claims abstract description 70
- 235000020638 mussel Nutrition 0.000 title claims abstract description 70
- 241000894006 Bacteria Species 0.000 title claims abstract description 30
- 230000003248 secreting effect Effects 0.000 title claims abstract description 15
- 238000010276 construction Methods 0.000 title claims abstract description 11
- 108010076504 Protein Sorting Signals Proteins 0.000 claims abstract description 40
- 239000013612 plasmid Substances 0.000 claims abstract description 22
- 238000000855 fermentation Methods 0.000 claims abstract description 19
- 230000004151 fermentation Effects 0.000 claims abstract description 19
- 241000588724 Escherichia coli Species 0.000 claims abstract description 17
- 108010005400 cutinase Proteins 0.000 claims abstract description 17
- 230000014509 gene expression Effects 0.000 claims abstract description 17
- 239000004094 surface-active agent Substances 0.000 claims abstract description 13
- 230000004927 fusion Effects 0.000 claims abstract description 4
- 239000002609 medium Substances 0.000 claims description 17
- 239000001963 growth medium Substances 0.000 claims description 13
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 11
- 239000012634 fragment Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 150000007523 nucleic acids Chemical group 0.000 claims description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 10
- 239000013604 expression vector Substances 0.000 claims description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 7
- 229960000723 ampicillin Drugs 0.000 claims description 7
- 229920004890 Triton X-100 Polymers 0.000 claims description 6
- 239000001888 Peptone Substances 0.000 claims description 5
- 108010080698 Peptones Proteins 0.000 claims description 5
- 239000000411 inducer Substances 0.000 claims description 5
- 235000019319 peptone Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 4
- 238000009630 liquid culture Methods 0.000 claims description 4
- 101150110245 ompC gene Proteins 0.000 claims description 4
- 230000004186 co-expression Effects 0.000 claims description 3
- 239000002054 inoculum Substances 0.000 claims description 3
- 101150087366 mglB gene Proteins 0.000 claims description 3
- 101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 claims description 2
- 101100278567 Lelliottia amnigena dsbL gene Proteins 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 101150042295 arfA gene Proteins 0.000 claims description 2
- 101150009558 dsbA gene Proteins 0.000 claims description 2
- 101150087557 omcB gene Proteins 0.000 claims description 2
- 101150115693 ompA gene Proteins 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 108700026220 vif Genes Proteins 0.000 claims description 2
- 230000028327 secretion Effects 0.000 abstract description 22
- 238000000034 method Methods 0.000 abstract description 5
- 238000010353 genetic engineering Methods 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract description 3
- 238000009825 accumulation Methods 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 239000006227 byproduct Substances 0.000 abstract 1
- 230000003013 cytotoxicity Effects 0.000 abstract 1
- 231100000135 cytotoxicity Toxicity 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 230000012743 protein tagging Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 238000011144 upstream manufacturing Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 12
- 108700028353 OmpC Proteins 0.000 description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- 239000011543 agarose gel Substances 0.000 description 6
- 210000001322 periplasm Anatomy 0.000 description 6
- 241001052560 Thallis Species 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 210000003000 inclusion body Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical group CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 102000006833 Multifunctional Enzymes Human genes 0.000 description 1
- 108010047290 Multifunctional Enzymes Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 101150049515 bla gene Proteins 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000012444 downstream purification process Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000007154 intracellular accumulation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
- 229960001237 podophyllotoxin Drugs 0.000 description 1
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 108010087967 type I signal peptidase Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01074—Cutinase (3.1.1.74)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a genetically engineered bacterium capable of secreting mussel proteins extracellularly, and a construction method and application thereof, and belongs to the technical field of genetic engineering. According to the invention, through signal peptide screening, the signal peptide and the mussel protein gene are connected and transferred into plasmid pET-Duet for fusion expression. Furthermore, the cutinase Tfu-0883 gene is transferred into plasmid pET-Duet, and is co-expressed with signal peptide-mussel protein fusion protein, so that the extracellular secretion of mussel protein is finally realized. In addition, the invention optimizes the fermentation medium by adding the surfactant, thereby improving the extracellular secretion level. The yield of mussel protein in the purified fermentation liquor can reach 20-40mg/L. The invention realizes extracellular secretion of the soluble mussel protein with bioactivity in the escherichia coli, weakens the cytotoxicity caused by product accumulation, promotes the continuous synthesis of the mussel protein, avoids the subsequent cell disruption operation, and optimizes the process.
Description
Technical Field
The invention belongs to the technical field of genetic engineering, and in particular relates to a genetically engineered bacterium capable of secreting mussel proteins extracellularly, and a construction method and application thereof.
Background
Mussels are a common bivalve mollusk. One class of adhesive proteins secreted by mussel foot silk glands is known as mussel foot silk proteins (Mfp). 6 foot proteins (Mfp-1 to Mfp-6) have been identified. Mussel protein has high strength and durable adhesion capability, and can maintain the stability of mussel under repeated flushing of water flow. In addition, the mussel protein has the advantages of good biocompatibility, no sensitization, no toxicity and the like, so that the mussel podophyllotoxin protein has wide application potential in a plurality of industries such as medicine, electronic equipment, automobile and aerospace industries, paint and the like.
The traditional mussel foot protein extraction method is a direct extraction method, and has high production cost and low extraction efficiency. The high price limits the research and utilization of mussel proteins, so people start to obtain Mfps by means of genetic engineering techniques. In recombinant protein expression systems, both prokaryotes and eukaryotes are reported as hosts. Commonly used prokaryotic hosts are mainly bacteria (E.coli), eukaryotic hosts include insects, yeasts (Saccharomyces cerevisiae, pichia pastoris, kluyveromyces lactis) and plants (tobacco, chicory). Expression of Mefp-1, mfp-5, mfp-3A, mcofp-1, -3, etc. in a prokaryotic host; expression of Mefp-3, mefp-1, mcfp-3, mgfp-5, etc., is achieved in eukaryotic hosts. Mussel foot proteins have not been produced on a large scale, mainly due to low heterologous expression yields. In addition, the intracellular reducing environment of the escherichia coli is not beneficial to the formation of disulfide bonds of proteins, so that the soluble proteins with biological activity are expressed less and are mostly expressed in the form of inclusion bodies. The oxidative periplasmic space provides a good environment for proper folding of the peptide chain and fewer proteolytic enzymes make the product less susceptible to degradation. However, the periplasmic space of the cells is limited, and a large volume of fermentation medium may be the best place for recombinant proteins. However, since E.coli has a double membrane and a complex periplasmic space, protein secretion needs to cross both inner and outer membranes, which is more difficult than gram-positive bacteria.
The Signal Peptide (SP) is a short peptide chain located at the N-terminus of the target protein and capable of directing the transfer of the protein to the periplasmic space. The signal peptide reaches the lumen of the endoplasmic reticulum via the channel formed by the protein in the membrane, and is then hydrolyzed by the signal peptidase located on the membrane surface. With the aid of signal peptides, nascent polypeptide chains are transferred from the cytoplasm into the periplasmic space of the cell, and folded in the periplasmic space, and finally secreted extracellularly. However, when a protein located in a cell is recombinantly expressed in E.coli, the protein cannot be secreted outside the cell even if a signal peptide is added to the target protein, and thus other means are required to assist in secretion of the target protein. Common means are to increase the export capacity of the target protein (enhancing signal peptide, enhancing transcription regulator, overexpressing transfer RNA, etc.), and to regulate cell membrane permeability (external disruption, key enzyme knockdown, lipid hydrolase, etc.).
Cutinase is a multifunctional enzyme that hydrolyzes various soluble esters and insoluble polymeric cutins, and the like. The cutinase has the hydrolytic activity of phospholipase and can realize the extracellular secretion of target protein through the hydrolytic action of phospholipid component in the cell membrane of colibacillus to raise the permeability of cell membrane. The surfactant can dissolve lipid substances in cell membranes from outside, increase the permeability of the cell membranes, and facilitate the secretion of target proteins to outside, thereby improving the extracellular secretion capacity.
At present, no research on extracellular secretion of mussel protein of a large intestine expression system is reported. In the previous research, the accumulation of the soluble mussel protein can generate toxic effect on thalli, so that the extracellular secretion of the soluble mussel protein is realized, the intracellular accumulation of a product is avoided, the thallus pressure is reduced, and the downstream purification process is simplified, thus having very important significance.
Disclosure of Invention
The invention aims to solve the technical problem of providing a genetically engineered bacterium capable of secreting mussel proteins extracellularly, aiming at the defects of the prior art.
The invention also solves the technical problem of providing a construction method of the genetically engineered bacterium for extracellularly secreting mussel proteins.
The invention also solves the technical problem of providing the application of the genetically engineered bacterium for extracellularly secreting mussel protein in the fermentation of mussel protein.
In order to solve the technical problems, the invention adopts the following technical scheme:
a genetically engineered bacterium for extracellularly secreting mussel protein takes E.coli BL21 (DE 3) as an expression host, and sequentially inserts a signal peptide gene, a mussel protein gene and a cutinase gene on an expression vector, wherein the signal peptide gene and the mussel protein gene are subjected to fusion expression and then co-expression with the cutinase gene.
Wherein the expression vector is pET-Duet (purchased in Norflu).
Wherein, the signal peptide is any one of Bla, ompC, mglB, ompA, dsbA and PelB, the nucleic acid sequences of which are shown in SEQ ID NO.3, 5, 7, 9, 11 and 13, and the corresponding amino acid sequences are shown in SEQ ID NO.4, 6, 8, 10, 12 and 14.
The preferred signal peptide is Bla, ompC, mglB, and the most preferred signal peptide is Bla.
Wherein the mussel protein is Mgfp-5, the nucleic acid sequence of the mussel protein is shown as SEQ ID NO.1, and the corresponding amino acid sequence is shown as SEQ ID NO. 2.
Wherein, the cutinase is cutinase Tfu-0883, the nucleic acid sequence of which is shown as SEQ ID NO.15, and the corresponding amino acid sequence is shown as SEQ ID NO. 16.
The invention also provides a construction method of the genetically engineered bacterium for extracellularly secreting mussel proteins, which comprises the following steps:
(1) Connecting the signal peptide with the mussel protein gene fragment by PCR, wherein the signal peptide is positioned at the N end of the mussel protein, and introducing the connected fragment into a polyclonal copy site of the plasmid pET-Duet to obtain the plasmid pET-Duet into which the signal peptide and the mussel protein gene are introduced;
(2) Introducing a cutinase gene into the other polyclonal copy site of the plasmid pET-Duet obtained in the step (1) into which the signal peptide and the mussel protein gene are introduced, so as to obtain a recombinant plasmid;
(3) And (3) introducing the recombinant plasmid obtained in the step (2) into E.coli BL21 (DE 3) for expression to obtain recombinant escherichia coli, namely the genetically engineered bacterium capable of secreting mussel proteins extracellularly.
The application of the genetically engineered bacterium for extracellularly secreting mussel protein in preparing the mussel protein by fermentation is also within the scope of the invention.
The application of the genetically engineered bacterium for extracellularly secreting mussel proteins in preparing the mussel proteins by fermentation comprises the following steps:
(a) Inoculating the genetically engineered bacterium of any one of claims 1-5 into a shake flask for culture after plate activation, and preparing seed liquid;
(b) Inoculating the seed liquid obtained in the step (a) into a liquid culture medium according to an inoculum size of 1-10% v/v for fermentation culture, and collecting fermentation supernatant and thalli.
Wherein in the step (a), the culture conditions are as follows: culturing at 35-40deg.C and 180-220rpm for 8-12 hr.
Preferred culture conditions are: the culture was continued overnight at 37℃with shaking at 200rpm for 10 hours.
In the step (a), the formula of the LB culture medium is as follows: 10g/L peptone, 5g/L yeast powder, 10g/L sodium chloride and 25-50. Mu.g/mL ampicillin.
Wherein in step (b), the seed solution is 1-10% v/v, preferably 10%.
Wherein in the step (b), the fermentation culture is performed under the following fermentation conditions: culturing at 35-40deg.C and 180-220rpm to OD 600 And adding an inducer when the concentration reaches 2-3 and the final concentration of the inducer is 0.1-1mM, and continuously culturing for 6-10h.
Specifically, the inducer is IPTG.
Preferred fermentation conditions are: culturing at 37℃and 200rpm to OD 600 IPTG was added to a final concentration of 1mM at 2-3 and the incubation was continued at 37℃and 200rpm for 6h.
Wherein in the step (b), the liquid culture medium is: 10-20g/L peptone, 5-10g/L yeast powder, 10-20g/L sodium chloride, 25-50 mu g/mL ampicillin and 1-5g/L surfactant.
Specifically, the surfactant is any one of Span-80, tween-60, triton-X100, SDS and dimethyl sulfoxide. A preferred surfactant is Triton-X100.
Wherein, in the step (b), the concentration of the extracellular secreted mussel protein can reach 20-40mg/L.
Preferably, the concentration of extracellular secreted mussel protein reaches 35-40mg/L.
The beneficial effects are that:
(1) The research firstly realizes the expression of mussel protein in escherichia coli, and finally realizes the extracellular secretion of the mussel protein through the fusion with signal peptide and the co-expression with cutinase. In addition, the yield of extracellular secretion is improved by optimizing the fermentation medium, which is beneficial to industrial production. The mussel protein prepared by the invention can be widely applied in the fields of medicine, instruments, coatings and the like.
(2) The invention establishes a method for realizing the extracellular secretion of mussel protein, so that the mussel protein can be directly extracted in a fermentation medium, the operation of crushing thalli is avoided, the process is optimized, and the secreted mussel protein is the soluble protein with biological activity.
Drawings
The foregoing and/or other advantages of the invention will become more apparent from the following detailed description of the invention when taken in conjunction with the accompanying drawings and detailed description.
FIG. 1 is a diagram of an extracellular secretion Mgfp-5 expression vector construction framework;
FIG. 2 shows SDS-PAGE analysis of Mgfp-5, M: protein standard molecular weight, S: intracellular soluble expressed Mgfp-5, IS: mgfp-5, E expressed by intracellular inclusion bodies: extracellular secreted Mgfp-5; (a) example 1: 1% of Triton-X100 was added to the medium, and the strain was a recombinant strain. (b) comparative example 1: 1% Triton-X100 was added to the medium and the strain was Mgfp-5 expressed alone (c) comparative example 2: the culture medium is free of surfactant, and the strain is recombinant strain. (d) comparative example 3: 1% Span-80 was added to the medium and the strain was a recombinant strain. (e) comparative example 4: the culture medium was supplemented with 1% Tween-80 and the strain was recombinant. (f) comparative example 5: the medium was supplemented with 1% SDS and the strain was recombinant.
FIG. 3 shows the growth curve of Mgfp-5 exocrine experiments.
FIG. 4 is a graph showing the yield of Mgfp-5 exocrine experiments.
FIG. 5 is an SDS-PAGE electrophoretic analysis of Mgfp-5 under different signal peptide conditions, M: protein standard molecular weight, S: intracellular soluble expressed Mgfp-5, IS: mgfp-5, E expressed by intracellular inclusion bodies: extracellular secreted Mgfp-5; example 1: the signal peptide is Bla, 1% of Trition-X100 is added to the culture medium, and the strain is recombinant strain. Example 2: the signal peptide was OmpC, 1% of Trition-X100 was added to the medium, and the strain was recombinant. Example 3: the signal peptide is MglB, 1% of Trition-X100 is added into the culture medium, and the strain is recombinant strain.
Detailed Description
The experimental methods described in the following examples are all conventional methods unless otherwise specified; the reagents and materials, unless otherwise specified, are commercially available.
In the following examples, the extracellular secreted mussel protein Mgfp-5 concentration was measured using the Bradford protein concentration assay kit.
Example 1: construction of genetically engineered bacteria for producing extracellular mussel protein Mgfp-5 and shake flask fermentation to prepare extracellular mussel protein Mgfp-5.
1. Obtaining Bla-Mgfp-5 Gene fragment
(1) Designing an upstream primer and a downstream primer according to the sequence of the coding region of Mgfp-5, wherein the designed primers are as follows:
the upstream primer 5-Bla-F:
5’-GGTGTTCGCCAAGCTTGAATTCAGCAGCGAAGAATA-3’
downstream primer 5-R:
5’-CGCAAGCTTGTGGTGATGATGGTGATGGGACGAACCG-3’
the PCR reaction system was 25. Mu.L: mgfp-5 genome template DNA 2. Mu.L, upstream and downstream primers 2. Mu.L, 2X Phanta Max Master Mix 12.5.5. Mu.L, ddH, respectively 2 O6.5. Mu.L. 2X Phanta Max Master Mix was purchased from Northenzan (Nanjing, china). The PCR reaction conditions were 94℃for 5min, followed by 94℃for 30s,60℃for 30s, and 72℃for 9s for 30 cycles, and finally 72℃for 10min. The PCR product was subjected to 1% agarose gel, and the result showed that there was a specific band below 250bp, and Mgfp-5 gene fragment was recovered by cutting gel.
Wherein, the nucleic acid sequence of the mussel protein Mgfp-5 is shown as SEQ ID NO.1, and the corresponding amino acid sequence is shown as SEQ ID NO. 2.
(2) Designing an upstream primer and a downstream primer according to the coding region sequence of the signal peptide Bla, wherein the designed primers are as follows:
the upstream primer Bla-F:
5’-AGATATACCATGGgcATGGGCATGAGCATTCAGCA-3’
downstream primer Bla-R:
5’-TATTCTTCGCTGCTGAATTCAAGCTTGGCGAACACC-3’
the PCR reaction system was 25. Mu.L: bla genome template DNA 2. Mu.L, upstream and downstream primers 2. Mu.L, 2X Phanta Max Master Mix 12.5.12.5. Mu.L, ddH, respectively 2 O6.5. Mu.L. 2X Phanta Max Master Mix was purchased from Northenzan (Nanjing, china). The PCR reaction conditions were 94℃for 5min, followed by 94℃for 30s,60℃for 30s, and 72℃for 3s for 30 cycles, and finally 72℃for 10min. The PCR product is subjected to 1% agarose gel, and the result shows that about 80bp has a specific band, and the Bla gene fragment is recovered by cutting gel.
Wherein, the nucleic acid sequence of the signal peptide Bla is shown as SEQ ID NO.3, and the corresponding amino acid sequence is shown as SEQ ID NO. 4.
(3) The gene fragments of Bla and Mgfp-5 were ligated by PCR, the upstream primer Bla-F and the downstream primer 5-R. The PCR reaction system is the same as in step 1 (1). The PCR reaction conditions were 94℃for 5min, followed by 94℃for 30s,60℃for 30s, and 72℃for 10s for 30 cycles, and finally 72℃for 10min. The PCR product is subjected to 1% agarose gel, and the result shows that a specific band exists at 300bp, and the Bla-Mgfp-5 gene fragment is obtained by cutting gel and recycling.
2. Acquisition of the cutinase Tfu-0883 Gene fragment
Designing an upstream primer and a downstream primer according to the coding region sequence of Tfu-0883, wherein the designed primers are as follows:
the upstream primer Tfu-F:
5’-TAAGAAGGAGATATACATATGGCAGTTATGACCCCGCGCC-3’
downstream primer Tfu-R:
5’-GTTTCTTTACCAGACTCGAGTTAAAACGGGCAGGTACTGC-3’
the PCR reaction system was 25. Mu.L: tfu-0883 genomic template DNA 2. Mu.L, upstream and downstream primers 2. Mu.L each, 2 XPhantaMaxMasterMix 12.5. Mu.L, ddH 2 O6.5. Mu.L. 2 x PhantaMaxMasterMix was purchased from Northenzan (Nanjing, china). The PCR reaction conditions were 94℃for 5min, followed by 94℃for 30s,60℃for 30s,72℃for 30s, and finally 72℃for 10min. The PCR product was subjected to 1% agarose gel, and the result showed that there was a specific band below 1000bp, and the Tfu-0883 gene fragment was recovered by cutting.
Wherein, the nucleic acid sequence of the cutinase Tfu-0883 is shown as SEQ ID NO.15, and the corresponding amino acid sequence is shown as SEQ ID NO. 16.
3. Construction of expression vector for extracellular secretion of mussel protein Mgfp-5
(1) The pET-Duet empty plasmid was extracted in small amounts. The PCR recovered product (Tfu-0883) was digested with restriction enzymes NdeI and XhoI together with plasmid pET-Duet (purchased from Yu Nuowei ZA), and the digested product was purified by 1% agarose gel and recovered for use.
(2) The cleavage product Tfu-0883 was ligated with the linearized pET-Duet plasmid. The reaction system is as follows: 5. Mu.L of linearization vector, 3. Mu.L of insert, 2. Mu.L of ExnaseII, 4. Mu.L of 5 XCEII Buffer, 6. Mu.L of ddH 2 O. ExnaseII and 5 XCEII Buffer were purchased from Novozan (Nanjing, china). After ice-bath reaction of 20. Mu.L of the reaction system for 30 minutes, 100. Mu.L of the reaction system was addedThe ice bath was continued for 30 minutes in the competent (Yu Nuowei praise) bacteria solution of the color DH 5. Alpha. After heat shock at 42℃for 60 to 90 seconds and recovery culture with 5-fold volume of LB liquid medium (no resistance) for 1 hour, a proper volume of plating plate (with 50. Mu.g/mL of ampicillin resistance) was used and cultured at 37℃for 12 hours. Screening monoclonal, culturing and extracting plasmid for sequencing to finally obtain the corresponding expression vector pET-Duet-Tfuu-0883. The recombinant plasmid is transferred into E.coli BL21 (DE 3) for expression.
(3) The pET-Duet-Tfu-0883 plasmid was extracted in small amounts. The PCR recovery product (Bla-Mgfp-5) and plasmid pET-Duet-Tfu-0883 are subjected to double digestion by restriction enzymes NcoI and HindIII, and the digested product is recovered for later use after purification by 1% agarose gel.
(4) The cleavage product Bla-Mgfp-5 was ligated with the linearized pET-Duet-Tfu-0883 plasmid. The reaction system is as follows: 5. Mu.L of linearization vector, 3. Mu.L of insert, 2. Mu.L of ExnaseII, 4. Mu.L of 5 XCEII Buffer, 6. Mu.L of ddH 2 O. ExnaseII and 5 XCEII Buffer were purchased from Novozan (Nanjing, china). After the reaction system of 20. Mu.L was ice-bathed for 30 minutes, 100. Mu.L of E.coli DH 5. Alpha. Competent bacteria solution was added thereto, and the ice-bath was continued for 30 minutes. After heat shock at 42℃for 60 to 90 seconds and recovery culture with 5 volumes of LB liquid medium (no resistance) for 1 hour, a proper volume of plating plate (with ampicillin resistance) was used and cultured at 37℃for 12 hours. Screening monoclonal, culturing, extracting plasmid and sequencing to obtain the expression vector pET-Duet-Bla-Mgfp-5-Tfu-0883 capable of realizing extracellular secretion of mussel protein Mgfp-5. The recombinant plasmid is transferred into E.coli BL21 (DE 3) for expression to obtain recombinant escherichia coli.
4. Preparation of extracellular mussel protein Mgfp-5 by shake flask fermentation
The recombinant E.coli strain obtained in step 3 was streaked on a plate. Single colonies grown on the plates were picked, inoculated in shake flasks with 5mL LB medium and incubated at 37℃overnight with shaking at 200rpm for 10h. Transfer to 1L baffle shake flask containing 200mL of liquid medium at 10% v/v inoculum size, and culture at 37℃at 200rpm to OD 600 IPTG was added to a final concentration of 1mM at 2-3 and the incubation was continued at 37℃and 200rpm for 6h. And after the culture is finished, respectively collecting fermentation supernatant and thalli. Purifying the fermentation supernatant by nickel column affinity chromatography to collect extracellular secretionMgfp-5 of (F). The thalli are subjected to ultrasonic crushing, and are divided into soluble Mgfp-5 and inclusion bodies after crushing. The expression of the recombinant protein was then determined by SDS-PAGE electrophoresis.
Wherein, the formula of the LB culture medium is as follows: 10g/L peptone, 5g/L yeast powder, 10g/L sodium chloride and 25-50. Mu.g/mL ampicillin; the formula of the liquid culture medium is as follows: 10g/L peptone, 5g/L yeast powder, 10g/L sodium chloride, 25-50. Mu.g/mL ampicillin and 1g/L Triton-X100.
Comparative example 1: other embodiments are the same as example 1 without introducing signal peptide and cutinase.
Comparative example 2: other embodiments are the same as example 1 without adding a surfactant to the liquid medium.
Comparative example 3: 1g/L Span-80 was added to the liquid medium, and the other embodiments were the same as in example 1.
Comparative example 4: tween-80 was added at 1g/L to the liquid medium, and the other embodiments were the same as in example 1.
Comparative example 5: 1g/L SDS was added to the liquid medium, and the other embodiments were the same as in example 1.
The results are shown in fig. 2, 3 and 4. In the embodiment 1 of the invention, the yield of extracellular secreted soluble Mgfp-5 reaches 35mg/L due to the adoption of the genetically engineered bacterium and the culture medium added with 1g/L of Trition-X100. The extracellular secretion expression level of comparative examples 2 to 4 was significantly lower than that of example 1, whereas comparative examples 1 and 5 were not secreted at all. The addition of surfactants affects cell growth, resulting in reduced biomass. Comparative example 2 was best grown since no surfactant was added, but the biomass of experimental example 1 was less decreased compared to comparative example 2 and grown better compared to other surfactants. In conclusion, the optimal extracellular secretion of Mgfp-5 is obtained by applying the recombinant genetically engineered bacteria and the optimized culture medium of the research.
Example 2: the signal peptide of example 1 was replaced with OmpC, and the other conditions were the same as those of example 1.
Wherein, the upstream primer 5-OmpC-F corresponding to Mgfp-5 is:
5’-GCAAATGCAAAGCTTGAATTCAGCAGCGAAGAATA-3’
the downstream primer 5-R corresponding to Mgfp-5 is unchanged.
Wherein, the upstream primer OmpC-F corresponding to the signal peptide OmpC is:
5’-GAGATATACCATGGgcATGGGCATGAAGGTTAAGG-3’
the downstream primer OmpC-R corresponding to OmpC is:
5’-TATTCTTCGCTGCTGAATTCAAGCTTTGCATTTGC-3’。
wherein the nucleic acid sequence of the signal peptide OmpC is shown as SEQ ID NO.5, and the corresponding amino acid sequence is shown as SEQ ID NO. 6.
Example 3: the signal peptide of example 1 was changed to MglB, and the other conditions were the same as in example 1.
Wherein, the upstream primer 5-MglB-F corresponding to Mgfp-5 is:
5’-CATGCCAAGCTTGAATTCAGCAGCGAAGAATACAA-3’
the downstream primer 5-R corresponding to Mgfp-5 is unchanged.
Wherein, the upstream primer MglB-F corresponding to MglB is:
5’-AGGAGATATACCATGGgcATGGGCATGAACAAGAA-3’
the downstream primer MglB-R corresponding to MglB is:
5’-TTGTATTCTTCGCTGCTGAATTCAAGCTTGGCATG-3’
wherein, the nucleic acid sequence of the signal peptide MglB is shown as SEQ ID NO.7, and the corresponding amino acid sequence is shown as SEQ ID NO. 8.
As a result, as shown in FIG. 5, in example 1, 1 g/LTtion-X100 surfactant was added instead of the signal peptide as compared with examples 2 and 3. As is clear from the figure, the three signal peptides Bla, ompC and MglB all can realize extracellular secretion of Mgfp-5, but Bla has the best secretion efficiency, the band is the most clear, and the secretion promoting effect of the signal peptides OmpC (20.5 mg/L) and MglB (24.5 mg/L) is superior.
The invention provides a genetically engineered bacterium for extracellular secretion of mussel proteins, a construction method and an application idea thereof, and a method and a way for realizing the technical scheme are more specific, the above is only a preferred embodiment of the invention, and it should be pointed out that a plurality of improvements and modifications can be made by a person skilled in the art without departing from the principle of the invention, and the improvements and modifications are also considered as the protection scope of the invention. The components not explicitly described in this embodiment can be implemented by using the prior art.
Claims (10)
1. A genetically engineered bacterium for extracellularly secreting mussel protein is characterized in that E.coli BL21 (DE 3) is taken as an expression host, and a signal peptide gene, a mussel protein gene and a cutinase gene are sequentially inserted into an expression vector, wherein the signal peptide gene and the mussel protein gene are subjected to fusion expression and then co-expression with the cutinase gene.
2. The genetically engineered bacterium of claim 1, wherein the expression vector is pET-durt.
3. The genetically engineered bacterium of claim 1, wherein the signal peptide is any one of Bla, ompC, mglB, ompA, dsbA and PelB, the nucleic acid sequence of which is shown in SEQ ID nos. 3, 5, 7, 9, 11, 13, and the corresponding amino acid sequences of which are shown in SEQ ID nos. 4, 6, 8, 10, 12, 14.
4. The genetically engineered bacterium of claim 1, wherein the mussel protein is Mgfp-5, the nucleic acid sequence of which is shown in SEQ ID No.1, and the corresponding amino acid sequence of which is shown in SEQ ID No. 2.
5. The genetically engineered bacterium of claim 1, wherein the cutinase is cutinase Tfu-0883, the nucleic acid sequence of which is shown in SEQ ID No.15, and the corresponding amino acid sequence of which is shown in SEQ ID No. 16.
6. The construction method of the genetically engineered bacterium for extracellularly secreting mussel proteins is characterized by comprising the following steps:
(1) Connecting the signal peptide with the mussel protein gene fragment by PCR, wherein the signal peptide is positioned at the N end of the mussel protein, and introducing the connected fragment into a polyclonal copy site of the plasmid pET-Duet to obtain the plasmid pET-Duet into which the signal peptide and the mussel protein gene are introduced;
(2) Introducing a cutinase gene into the other polyclonal copy site of the plasmid pET-Duet obtained in the step (1) into which the signal peptide and the mussel protein gene are introduced, so as to obtain a recombinant plasmid;
(3) And (3) introducing the recombinant plasmid obtained in the step (2) into E.coli BL21 (DE 3) for expression to obtain recombinant escherichia coli, namely the genetically engineered bacterium capable of secreting mussel proteins extracellularly.
7. Use of the genetically engineered bacterium that exogenously secretes mussel proteins according to any one of claims 1-5 in the fermentative preparation of mussel proteins.
8. The use according to claim 7, characterized by the steps of:
(a) Inoculating the genetically engineered bacterium of any one of claims 1-5 into a shake flask containing an LB culture medium for culture after plate activation, and preparing seed liquid;
(b) Inoculating the seed solution obtained in the step (a) into a liquid culture medium according to an inoculum size of 1-10% v/v for fermentation culture to obtain extracellular secreted mussel protein.
9. The use according to claim 8, wherein in step (a), the culturing is performed under the following conditions: culturing at 35-40deg.C and 180-220rpm for 8-12 hr; in the step (b), the fermentation culture is carried out under the following culture conditions: culturing at 35-40deg.C and 180-220rpm to OD 600 And adding an inducer when the concentration reaches 2-3 and the final concentration of the inducer is 0.1-1mM, and continuously culturing for 6-10h.
10. The use according to claim 8, wherein in step (b), the liquid medium is: 10-20g/L peptone, 5-10g/L yeast powder, 10-20g/L sodium chloride, 25-50 mu g/mL ampicillin and 1-5g/L surfactant; wherein the surfactant is any one of Span-80, tween-60, triton-X100, SDS and dimethyl sulfoxide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310168298.6A CN116042502A (en) | 2023-02-27 | 2023-02-27 | Genetically engineered bacterium capable of secreting mussel protein extracellularly, construction method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310168298.6A CN116042502A (en) | 2023-02-27 | 2023-02-27 | Genetically engineered bacterium capable of secreting mussel protein extracellularly, construction method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116042502A true CN116042502A (en) | 2023-05-02 |
Family
ID=86120190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310168298.6A Pending CN116042502A (en) | 2023-02-27 | 2023-02-27 | Genetically engineered bacterium capable of secreting mussel protein extracellularly, construction method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116042502A (en) |
-
2023
- 2023-02-27 CN CN202310168298.6A patent/CN116042502A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101253196B (en) | Cleavage of precursors of insulins by a variant of trypsin | |
CN102239183B (en) | The screening of the albumen of a large amount of secretions is applied as fusion partner with them in recombinant protein preparation | |
CN101501209A (en) | A method of producing biologically active polypeptide having insulinotropic activity | |
CN113265346B (en) | Genetically engineered bacterium for producing porcine myoglobin through fermentation and application thereof | |
CN107574173B (en) | Recombinant plasmid and method for constructing monascus pigment high-yield strain by using same | |
CN112725319B (en) | Alginate lyase FaAly7 with polyG substrate specificity and application thereof | |
CN108034667B (en) | Monascus ruber alpha-amylase gene, and preparation method and application thereof | |
CN113234699A (en) | Alpha-1, 2-fucosyltransferase and application thereof | |
US11807883B2 (en) | Polypeptide tag, highly soluble recombinant nitrilase and application thereof in synthesis of pharmaceutical chemicals | |
CN104195157A (en) | High-efficiency recombination expression and purification method of biological active peptide in prokaryotic cells | |
CN113106112A (en) | Genetically engineered bacterium for heterologous expression of xanthan gum endonuclease and application thereof | |
CN114761553A (en) | Nucleic acids, vectors, host cells and methods for producing beta-fructofuranosidase from aspergillus niger | |
TWI282370B (en) | Improved method for the recombinant production of polypeptides | |
CN116042502A (en) | Genetically engineered bacterium capable of secreting mussel protein extracellularly, construction method and application thereof | |
CN111471667B (en) | Chitosanase Csn-PT and application thereof | |
CN112011494B (en) | Recombinant escherichia coli and application thereof in synthesis of aspartame through whole-cell transformation | |
CN114746548A (en) | Nucleic acids, vectors, host cells and methods for producing fructosyltransferase from aspergillus japonicus | |
RU2453604C1 (en) | Hybrid protein (versions), bacterial strain escherichia coli - hybrid protein producer (versions) and method for producing methionine-free human interferon alpha-2 | |
CN112725315A (en) | Application of chitosanase and mutant thereof in preparation of chitosan oligosaccharide | |
US11866714B2 (en) | Promoter for yeast | |
RU2593172C2 (en) | RECOMBINANT PLASMID DNA pER-TA1 GyrA-AcSer CODING SERINE ACETYLTRANSFERASE CAPABLE OF in vivo ACETYLATION OF N-TERMINAL SERINE DEACETYL-THYMOSIN α1 AND HYBRID PROTEIN CAPABLE OF AUTOCATALYTIC BREAKDOWN TO FORM HUMAN THYMOSIN α1, STRAIN OF Eschrichia coli C3030/pER-TA1GyrA-AcSer PRODUCER OF SAID PROTEINS AND METHOD OF PRODUCING GENETICALLY ENGINEERED HUMAN THYMOSIN | |
CN114107260B (en) | Fucoidan sulfate degrading enzyme OUC-FaFcn1 and application thereof | |
CN114277044B (en) | Genetically engineered bacterium for secreting gellan gum lyase and specifically degrading gellan gum and application thereof | |
CN100537754C (en) | A kind of S-adenosylmethionine is produced the structure and the large scale fermentation of bacterial strain | |
CN113462713B (en) | Method for improving expression level of glucagon-like peptide hexa-linked peptide in pichia pastoris |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |